These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8407853)

  • 1. Dexamethasone suppression test and onset of poststroke depression in patients with ischemic infarction.
    Harney JH; Fulton C; Ross ED; Rush AJ
    J Clin Psychiatry; 1993 Sep; 54(9):343-8. PubMed ID: 8407853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dexamethasone suppression test and mood following stroke.
    Lipsey JR; Robinson RG; Pearlson GD; Rao K; Price TR
    Am J Psychiatry; 1985 Mar; 142(3):318-23. PubMed ID: 3970268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test in bulimia: nonsuppression associated with depression and suboptimal weight.
    Perez EL; Blouin J; Blouin A
    J Clin Psychiatry; 1988 Mar; 49(3):94-6. PubMed ID: 3346203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between depression and the dexamethasone suppression test following alcohol withdrawal in a psychiatric population.
    Johnson B; Perry JC
    J Clin Psychopharmacol; 1986 Dec; 6(6):343-9. PubMed ID: 3805327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dexamethasone suppression test, poststroke depression, and the validity of DSM-III-based diagnostic criteria.
    Ross ED; Gordon WA; Hibbard M; Egelko S
    Am J Psychiatry; 1986 Sep; 143(9):1200-1. PubMed ID: 3752314
    [No Abstract]   [Full Text] [Related]  

  • 6. A two-year longitudinal study of poststroke mood disorders. In-hospital prognostic factors associated with six-month outcome.
    Robinson RG; Starr LB; Lipsey JR; Rao K; Price TR
    J Nerv Ment Dis; 1985 Apr; 173(4):221-6. PubMed ID: 3981156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood, vegetative disturbance, and dexamethasone suppression test after stroke.
    Finklestein S; Benowitz LI; Baldessarini RJ; Arana GW; Levine D; Woo E; Bear D; Moya K; Stoll AL
    Ann Neurol; 1982 Nov; 12(5):463-8. PubMed ID: 6960804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression test in adolescent psychiatric inpatients.
    Targum SD; Capodanno AE
    Am J Psychiatry; 1983 May; 140(5):589-91. PubMed ID: 6846588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone suppression in depressed elderly outpatients.
    Allen RE; Pitts FN
    J Clin Psychiatry; 1984 Sep; 45(9):397-8. PubMed ID: 6469926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obsessive-compulsive disorder, depression, and the dexamethasone suppression test.
    Jenike MA; Baer L; Brotman AW; Goff DC; Minichiello WE; Regan NJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):182-4. PubMed ID: 3597805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlations between clinico-psychiatric findings and the dexamethasone suppression test in depression].
    Rupprecht R; Barocka A; Pichl J
    Psychiatr Prax; 1988 Jul; 15(4):142-5. PubMed ID: 3406225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone suppression test and depression in a rehabilitation setting.
    Bauer M; Gans JS; Harley JP; Cobb W
    Arch Phys Med Rehabil; 1983 Sep; 64(9):421-2. PubMed ID: 6615180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry.
    Am J Psychiatry; 1987 Oct; 144(10):1253-62. PubMed ID: 3310667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppression test in depressive stroke patients.
    Dam H; Pedersen HE; Damkjaer M; Ahlgren P
    Acta Neurol Scand; 1991 Jul; 84(1):14-7. PubMed ID: 1927256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: a confirmatory report.
    Cottraux JA; Bouvard M; Claustrat B; Juenet C
    Psychiatry Res; 1984 Oct; 13(2):157-65. PubMed ID: 6596583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test. An indicator of depression in stroke but not a predictor of rehabilitation outcome.
    Reding M; Orto L; Willensky P; Fortuna I; Day N; Steiner SF; Gehr L; McDowell F
    Arch Neurol; 1985 Mar; 42(3):209-12. PubMed ID: 3977650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DST studies in psychotic depression: a meta-analysis.
    Nelson JC; Davis JM
    Am J Psychiatry; 1997 Nov; 154(11):1497-503. PubMed ID: 9356556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.